Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development

Michael Peter Diamond, ZoéY Y. Pettway, Julia Logan, Kelle Moley, William Vaughn, Alan H. DeCherney

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The diabetic state, as well as elevated culture media glucose level (950 mg d-glucose/dL) per se, significantly retards in vitro development of mouse pre-implantation embryos from a two-cell stage to blastocyst stage; maternal insulin therapy to diabetic mice reverses this impairment. This study was undertaken to assess (1) whether less extreme elevation of the media glucose concentration would also impair development, and (2) whether elevated culture media insulin or glucagon levels would alter development. Two-cell pre-embryos were recovered from B6C3F1 mice that had been stimulated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hGG), mated, and killed 48 hours later. Pre-embryos were observed in culture at 24-hour intervals for a total of 72 hours at four glucose levels: 110 (n = 108), 220 (n = 101), 440 (n = 65), and 950 (n = 106) mg d-glucose/dL. Impairment in progression of development was noted at each time period; compared with development in 110 mg glucose/dL, the distribution of development was significantly different at 24 hours (χ2 = 60.1, P < .001), at 48 hours (χ2 = 36.7, P < .001), and at 72 hours (χ2 = 45.1, P < .001). Rate of development as assessed by ANOVA was also significantly reduced at increasing glucose levels (P < .0001), with Duncan Multiple Range test demonstrating differences between development at higher glucose levels in the comparison of development in 110 mg/dL versus 440 mg/dL and 950 mg/dL, and at 220 mg/dL versus 950 mg/dL. Comparison of pre-embryo growth at different insulin concentrations, or in the presence of glucagon, showed no significant effect on pre-embryo growth and development compared with controls. We conclude that elevations of glucose to levels of 440 mg/dL can cause significant impairment of pre-embryo growth and development.

Original languageEnglish (US)
Pages (from-to)566-570
Number of pages5
JournalMetabolism
Volume40
Issue number6
DOIs
StatePublished - Jun 1991
Externally publishedYes

Fingerprint

Glucagon
Embryonic Development
Insulin
Glucose
Embryonic Structures
Growth and Development
Culture Media
Equine Gonadotropins
Blastocyst
Chorionic Gonadotropin
Analysis of Variance
Mothers
Growth

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development. / Diamond, Michael Peter; Pettway, ZoéY Y.; Logan, Julia; Moley, Kelle; Vaughn, William; DeCherney, Alan H.

In: Metabolism, Vol. 40, No. 6, 06.1991, p. 566-570.

Research output: Contribution to journalArticle

Diamond, MP, Pettway, ZY, Logan, J, Moley, K, Vaughn, W & DeCherney, AH 1991, 'Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development', Metabolism, vol. 40, no. 6, pp. 566-570. https://doi.org/10.1016/0026-0495(91)90045-X
Diamond, Michael Peter ; Pettway, ZoéY Y. ; Logan, Julia ; Moley, Kelle ; Vaughn, William ; DeCherney, Alan H. / Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development. In: Metabolism. 1991 ; Vol. 40, No. 6. pp. 566-570.
@article{caeb433f14714678a5e4b89e0b3eeabf,
title = "Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development",
abstract = "The diabetic state, as well as elevated culture media glucose level (950 mg d-glucose/dL) per se, significantly retards in vitro development of mouse pre-implantation embryos from a two-cell stage to blastocyst stage; maternal insulin therapy to diabetic mice reverses this impairment. This study was undertaken to assess (1) whether less extreme elevation of the media glucose concentration would also impair development, and (2) whether elevated culture media insulin or glucagon levels would alter development. Two-cell pre-embryos were recovered from B6C3F1 mice that had been stimulated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hGG), mated, and killed 48 hours later. Pre-embryos were observed in culture at 24-hour intervals for a total of 72 hours at four glucose levels: 110 (n = 108), 220 (n = 101), 440 (n = 65), and 950 (n = 106) mg d-glucose/dL. Impairment in progression of development was noted at each time period; compared with development in 110 mg glucose/dL, the distribution of development was significantly different at 24 hours (χ2 = 60.1, P < .001), at 48 hours (χ2 = 36.7, P < .001), and at 72 hours (χ2 = 45.1, P < .001). Rate of development as assessed by ANOVA was also significantly reduced at increasing glucose levels (P < .0001), with Duncan Multiple Range test demonstrating differences between development at higher glucose levels in the comparison of development in 110 mg/dL versus 440 mg/dL and 950 mg/dL, and at 220 mg/dL versus 950 mg/dL. Comparison of pre-embryo growth at different insulin concentrations, or in the presence of glucagon, showed no significant effect on pre-embryo growth and development compared with controls. We conclude that elevations of glucose to levels of 440 mg/dL can cause significant impairment of pre-embryo growth and development.",
author = "Diamond, {Michael Peter} and Pettway, {Zo{\'e}Y Y.} and Julia Logan and Kelle Moley and William Vaughn and DeCherney, {Alan H.}",
year = "1991",
month = "6",
doi = "10.1016/0026-0495(91)90045-X",
language = "English (US)",
volume = "40",
pages = "566--570",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development

AU - Diamond, Michael Peter

AU - Pettway, ZoéY Y.

AU - Logan, Julia

AU - Moley, Kelle

AU - Vaughn, William

AU - DeCherney, Alan H.

PY - 1991/6

Y1 - 1991/6

N2 - The diabetic state, as well as elevated culture media glucose level (950 mg d-glucose/dL) per se, significantly retards in vitro development of mouse pre-implantation embryos from a two-cell stage to blastocyst stage; maternal insulin therapy to diabetic mice reverses this impairment. This study was undertaken to assess (1) whether less extreme elevation of the media glucose concentration would also impair development, and (2) whether elevated culture media insulin or glucagon levels would alter development. Two-cell pre-embryos were recovered from B6C3F1 mice that had been stimulated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hGG), mated, and killed 48 hours later. Pre-embryos were observed in culture at 24-hour intervals for a total of 72 hours at four glucose levels: 110 (n = 108), 220 (n = 101), 440 (n = 65), and 950 (n = 106) mg d-glucose/dL. Impairment in progression of development was noted at each time period; compared with development in 110 mg glucose/dL, the distribution of development was significantly different at 24 hours (χ2 = 60.1, P < .001), at 48 hours (χ2 = 36.7, P < .001), and at 72 hours (χ2 = 45.1, P < .001). Rate of development as assessed by ANOVA was also significantly reduced at increasing glucose levels (P < .0001), with Duncan Multiple Range test demonstrating differences between development at higher glucose levels in the comparison of development in 110 mg/dL versus 440 mg/dL and 950 mg/dL, and at 220 mg/dL versus 950 mg/dL. Comparison of pre-embryo growth at different insulin concentrations, or in the presence of glucagon, showed no significant effect on pre-embryo growth and development compared with controls. We conclude that elevations of glucose to levels of 440 mg/dL can cause significant impairment of pre-embryo growth and development.

AB - The diabetic state, as well as elevated culture media glucose level (950 mg d-glucose/dL) per se, significantly retards in vitro development of mouse pre-implantation embryos from a two-cell stage to blastocyst stage; maternal insulin therapy to diabetic mice reverses this impairment. This study was undertaken to assess (1) whether less extreme elevation of the media glucose concentration would also impair development, and (2) whether elevated culture media insulin or glucagon levels would alter development. Two-cell pre-embryos were recovered from B6C3F1 mice that had been stimulated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hGG), mated, and killed 48 hours later. Pre-embryos were observed in culture at 24-hour intervals for a total of 72 hours at four glucose levels: 110 (n = 108), 220 (n = 101), 440 (n = 65), and 950 (n = 106) mg d-glucose/dL. Impairment in progression of development was noted at each time period; compared with development in 110 mg glucose/dL, the distribution of development was significantly different at 24 hours (χ2 = 60.1, P < .001), at 48 hours (χ2 = 36.7, P < .001), and at 72 hours (χ2 = 45.1, P < .001). Rate of development as assessed by ANOVA was also significantly reduced at increasing glucose levels (P < .0001), with Duncan Multiple Range test demonstrating differences between development at higher glucose levels in the comparison of development in 110 mg/dL versus 440 mg/dL and 950 mg/dL, and at 220 mg/dL versus 950 mg/dL. Comparison of pre-embryo growth at different insulin concentrations, or in the presence of glucagon, showed no significant effect on pre-embryo growth and development compared with controls. We conclude that elevations of glucose to levels of 440 mg/dL can cause significant impairment of pre-embryo growth and development.

UR - http://www.scopus.com/inward/record.url?scp=0025890080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025890080&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(91)90045-X

DO - 10.1016/0026-0495(91)90045-X

M3 - Article

C2 - 1865820

AN - SCOPUS:0025890080

VL - 40

SP - 566

EP - 570

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 6

ER -